In this episode, we will hear all of the tips and tricks to success when looking to submit your research to Ophthalmologica.

Faculty: Martin Zinkernagel (Ophthalmologica editors) and Marco Casola (Karger).

Chaired by Jonathan McCrea

In this episode, Edoardo Midena (Italy) chairs a discussion with four leading experts in Diabetic Retinopathy from across the world: Jakob Grauslund (Denmark), Carol Cheung (Hong Kong), Enrico Borrelli (Italy) and Daniel Ting (Singapore)

In this episode, Siegfried Priglinger (Germany) and Roxane Hillier (UK) take a look at treatment for macula-off RRD. They're joined by David Yorston (Scotland) and Julian Klaas (Germany) and will ask - how do we best define "macula-off" and when should we start treatment?

Treating rare diseases can sometimes be challenging due a the lack of literature. In this episode, Carlos Pavesio (UK) asks leading experts Sara Touhami (France) and Moncef Khairallah (Tunisia) about their approaches to the diagnosis and treatment of Acute Retinal Necrosis (ARN).

In this podcast, David Steel tells Alistair Laidlaw what he's learned from zeroing in on individual patient data and how factors like posture and hole size affect his decision-making in the treatment of macular holes

In this episode, Euretina President Alistair Laidlaw chairs a discussion with Nicole Eter (München University Medical Centre) and Brendan Strong, Head of Education at Agenda about the new EBO examination.

In this in-depth podcast, Euretina President-Elect Ramin Tadayoni (France) chairs a discussion with Kyoko Ohno Matsui (Japan) and David Gaucher (France) exploring everything you need to know when dealing with the “bad guy” in myopia - Staphyloma.

Panel: Prof Ramin Tadayoni, University Of Paris Cite, Lariboisière, Saint Louis And Adolphe De Rothschild Foundation Hospitals, France

Kyoko Ohno Matsui Tokyo Medical And Dental University, Japan

David Gaucher Dept Of Ophthalmology, University Of Strasbourg, France

In this episode, Hibba Quhill (UK) explores each of the components that make up the MOLES system used for management of melanocytic choroidal tumours with the system's originator, Bertil Damato (UK/Sweden).